NSE filing, NSE: RPEL. Summary written from the filing by ALFA Finder's alert engine.
Raghav Productivity Enhancers Ltd: key numbers
- Share price
- ₹1,677.90
- Market cap
- ₹7,705 Cr
- Revenue (annual)
- ₹257.1 Cr
- Net profit (annual)
- ₹54.80 Cr
- P/E (TTM)
- 109.3×Sector 52.8×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raghav Productivity Enhancers Ltd
All →Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Raghav Productivity Enhancers Merger & Restructuring
RPEL acquired 80% of JV entity RPEL TRLK Silicatech Pvt Ltd for Rs. 80,000. The Odisha-based entity will manufacture silica ramming mass and refractories.
Raghav Productivity Enhancers Results Update
Raghav Productivity Enhancers Limited reported record H1 FY27 results with revenue of ₹180 Crore and 64% PAT growth. Capacity expansion to 5,34,000 MTPA is on track.
- manufacturing capacity
- 120000.0 MTPA
Raghav Productivity Enhancers Q2 FY27 Results: Net Profit ₹21.6 Cr, Up 56.5% YoY
Raghav Productivity Enhancers Ltd reported revenue from operations of ₹92.8 Cr (+45.9% YoY) and net profit of ₹21.6 Cr (+56.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.6 Cr · +56.5% YoY
Raghav Productivity Enhancers Board Meeting Date
Raghav Productivity Enhancers Ltd has scheduled a board meeting for October 16, 2026. The board will consider and approve un-audited financial results for the quarter ended September 30, 2026.
Raghav Productivity Enhancers Other Announcement
Raghav Productivity Enhancers Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI Regulation 31(1)(b).
Other management change announcements
All →Gland Pharma Management Change
Gland Pharma appointed Ajay Sahni as CEO of its wholly-owned subsidiary Gland Pharma International Pte. Ltd, effective 2 November 2026. He will lead the Cenexi business.
Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
West Leisure Resorts Management Change
West Leisure Resorts announced the resignation of non-executive director Radha Chotalia, effective close of business October 30, 2026. She cited personal reasons and no other material reasons.
Emami Paper Mills Management Change
Emami Paper Mills re-appointed independent directors Amit Kiran Deb and Sumit Banerjee for five years from 20 January 2027. Ernst & Young LLP was re-appointed internal auditor.
- Execution
- 60 months for independent directors from 20-01-2027; 24 months for internal auditor from 01-10-2026
Siemens Energy India Management Change
Siemens Energy India disclosed the October 30, 2026 resignation of Execution Unit Finance Head Satyajit Ghosh. He is moving to Siemens Energy AG group roles.
Dhunseri Investments Management Change
Dhunseri Investments appointed Aditi Kanodia as a Non-Executive Independent Director for five years from 23 September 2026. Shareholders approved it by postal ballot on 29 October 2026.